Michael D Hughes Selected Research

octane

10/2019	Linked dual-class HIV resistance mutations are associated with treatment failure.
6/2014	Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE).
4/2012	Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael D Hughes Research Topics

Disease

16	Acquired Immunodeficiency Syndrome (AIDS) 10/2019 - 06/2002
12	HIV Infections (HIV Infection) 01/2021 - 05/2002
10	Infections 01/2022 - 06/2002
9	Disease Progression 12/2021 - 11/2003
4	COVID-19 12/2022 - 12/2021
3	Viremia 01/2021 - 07/2012
3	Weight Gain 01/2019 - 07/2013
2	Tuberculosis (Tuberculoses) 01/2022 - 01/2020
2	Insulin Resistance 09/2021 - 07/2008
2	Atherosclerosis 01/2021 - 07/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2014
2	Human Influenza (Influenza) 01/2020 - 12/2017
2	Hepatitis 01/2018 - 04/2012
2	Birth Weight (Birth Weights) 01/2018 - 05/2002
2	Hepatitis C 01/2018 - 02/2013
2	Neutropenia 01/2018 - 01/2013
2	Anemia 01/2013 - 04/2011
1	Type 2 Diabetes Mellitus (MODY) 09/2021
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Diarrhea 01/2020
1	Body Weight (Weight, Body) 01/2019
1	Obesity 01/2019
1	Overweight 09/2015
1	Renal Insufficiency (Renal Failure) 05/2014
1	Inflammation (Inflammations) 01/2014
1	Maternal Death 07/2013
1	Pre-Eclampsia (Preeclampsia) 04/2013
1	Coinfection 02/2013
1	Exanthema (Rash) 04/2012
1	Malaria 02/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2009
1	Epstein-Barr Virus Infections 03/2009
1	Lymphoma (Lymphomas) 03/2009

Drug/Important Bio-Agent (IBA)

6	RNA (Ribonucleic Acid)IBA 12/2021 - 06/2005
6	Protease Inhibitors (Protease Inhibitor)IBA 01/2019 - 06/2002
5	Nevirapine (Viramune)FDA Link 10/2019 - 10/2010
5	vicrivirocIBA 08/2010 - 07/2007
4	Antiviral Agents (Antivirals)IBA 12/2021 - 12/2017
4	Tenofovir (Viread)FDA Link 10/2019 - 05/2014
4	Ritonavir (Norvir)FDA Link 01/2018 - 02/2012
4	Zidovudine (Retrovir)FDA LinkGeneric 09/2015 - 06/2002
3	Monoclonal AntibodiesIBA 01/2022 - 12/2021
3	octaneIBA 10/2019 - 04/2012
3	Reverse Transcriptase InhibitorsIBA 01/2018 - 05/2007
3	Lopinavir FDA Link 01/2018 - 02/2012
3	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2018 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 01/2014 - 10/2008
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 01/2020
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2022 - 01/2020
2	AntigensIBA 12/2021 - 03/2009
2	Insulin (Novolin)FDA Link 09/2021 - 07/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2009
2	Oseltamivir (Tamiflu)FDA Link 01/2020 - 12/2017
2	Emtricitabine (Emtriva)FDA Link 10/2019 - 09/2015
2	Pharmaceutical PreparationsIBA 10/2019 - 12/2017
2	SofosbuvirIBA 01/2019 - 01/2018
2	InterleukinsIBA 01/2019 - 02/2004
2	sofosbuvir drug combination ledipasvirIBA 01/2019 - 01/2018
2	Alanine Transaminase (SGPT)IBA 01/2018 - 02/2013
2	efavirenz (Sustiva)FDA Link 09/2015 - 04/2011
2	Lamivudine (Epivir)FDA Link 09/2015 - 06/2002
2	CreatinineIBA 05/2014 - 02/2013
2	NucleosidesIBA 05/2007 - 06/2002
1	cilgavimabIBA 12/2022
1	tixagevimabIBA 12/2022
1	cilgavimab and tixagevimab drug combinationIBA 12/2022
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 01/2022
1	bamlanivimabIBA 12/2021
1	Nucleic AcidsIBA 12/2021
1	Glucose (Dextrose)FDA LinkGeneric 09/2021
1	EndotoxinsIBA 09/2021
1	Inulin FDA Link 09/2021
1	PrebioticsIBA 09/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	VaccinesIBA 01/2020
1	Tuberculin (PPD)IBA 01/2020
1	InterferonsIBA 01/2019
1	CytokinesIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	Amantadine (Aman)FDA LinkGeneric 12/2017
1	Ribavirin (Virazole)FDA LinkGeneric 12/2017
1	RacivirIBA 09/2015
1	Vitamin D FDA LinkGeneric 11/2014
1	C-Reactive ProteinIBA 01/2014
1	LeptinIBA 07/2013
1	Tyrosine (L-Tyrosine)FDA Link 04/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2013
1	Hemoglobins (Hemoglobin)IBA 02/2013
1	Aspartic Acid (Aspartate)FDA Link 02/2013
1	Human immunodeficiency virus 1 p16 proteaseIBA 02/2012
1	IronIBA 04/2011

Therapy/Procedure

17	Therapeutics 01/2022 - 05/2002
8	Highly Active Antiretroviral Therapy (HAART) 07/2013 - 06/2002
6	Art Therapy 01/2021 - 02/2012
1	Glycemic Control 01/2019
1	Fat-Restricted Diet (Diet, Fat Restricted) 01/2019
1	Feeding Methods 01/2013
1	Secondary Prevention 07/2012